Our findings suggest that elevated CEACAM1 expression in CRC patients with disrupted TGF-β signaling facilitates increased microbial adhesion and entry, potentially exploited by altered microbiome observed in the OTM microbiota. The gene discussed is CEACAM1; the disease is colorectal carcinoma.